The DOI matches its Crossref record; 92 of the 92 references it cites were found in a registry or an index.
Aldose Reductase, Oxidative Stress, and Diabetic Mellitus
Open accessAbstract
Diabetes mellitus (DM) is a complex metabolic disorder arising from lack of insulin production or insulin resistance (Diagnosis and classification of diabetes mellitus, 2007). DM is a leading cause of morbidity and mortality in the developed world, particularly from vascular complications such as atherothrombosis in the coronary vessels. Aldose reductase (AR; ALR2; EC 1.1.1.21), a key enzyme in the polyol pathway, catalyzes nicotinamide adenosine dinucleotide phosphate-dependent reduction of glucose to sorbitol, leading to excessive accumulation of intracellular reactive oxygen species (ROS) in various tissues of DM including the heart, vasculature, neurons, eyes, and kidneys. As an example, hyperglycemia through such polyol pathway induced oxidative stress, may have dual heart actions, on coronary blood vessel (atherothrombosis) and myocardium (heart failure) leading to severe morbidity and mortality (reviewed in Heather and Clarke, 2011). In cells cultured under high glucose conditions, many studies have demonstrated similar AR-dependent increases in ROS production, confirming AR as an important factor for the pathogenesis of many diabetic complications. Moreover, recent studies have shown that AR inhibitors may be able to prevent or delay the onset of cardiovascular complications such as ischemia/reperfusion injury, atherosclerosis, and atherothrombosis. In this review, we will focus on describing pivotal roles of AR in the pathogenesis of cardiovascular diseases as well as other diabetic complications, and the potential use of AR inhibitors as an emerging therapeutic strategy in preventing DM complications.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnosis and Classification of Diabetes Mellitus
American Diabetes Association (2011) · Diabetes Care · doi:10.2337/dc11-s062 · Cited by 13,988
Haffner, S. M., Lehto, S., Rönnemaa, T., Pyörälä, K., & Laakso, M. (1998) · New England Journal of Medicine · doi:10.1056/nejm199807233390404 · Cited by 7,000
Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage
Nishikawa, T., Edelstein, D., Du, X. L., Yamagishi, S.-I., Matsumura, T., Kaneda, Y., Yorek, M. A., Beebe, D., Oates, P. J., Hammes, H.-P., et al. (2000) · Nature · doi:10.1038/35008121 · Cited by 4,277
New type of cardiomyopathy associated with diabetic glomerulosclerosis
Rubler, S., Dlugash, J., Yuceoglu, Y. Z., Kumral, T., Branwood, A. W., & Grishman, A. (1972) · The American Journal of Cardiology · doi:10.1016/0002-9149(72)90595-4 · Cited by 1,837
Wolff, S. P., & Dean, R. T. (1987) · Biochemical Journal · doi:10.1042/bj2450243 · Cited by 1,271
Projection of Diabetes Burden Through 2050
Boyle, J. P., Honeycutt, A. A., Narayan, K. M. V., Hoerger, T. J., Geiss, L. S., Chen, H., & Thompson, T. J. (2001) · Diabetes Care · doi:10.2337/diacare.24.11.1936 · Cited by 1,004 · cited 1×
“%) to 29 million in 2050 (prevalence of 7.2%; Boyle et al., 2001).”
InfluentialFlier, J. S., Underhill, L. H., Greene, D. A., Lattimer, S. A., & Sima, A. A. F. (1987) · New England Journal of Medicine · doi:10.1056/nejm198703053161007 · Cited by 897
WANG, X., MARTINDALE, J. L., LIU, Y., & HOLBROOK, N. J. (1998) · Biochemical Journal · doi:10.1042/bj3330291 · Cited by 736
Mullarkey, C. J., Edelstein, D., & Brownlee, M. (1990) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(05)80875-7 · Cited by 690
Schmidt, A. M., Hori, O., Brett, J., Yan, S. D., Wautier, J. L., & Stern, D. (1994) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.14.10.1521 · Cited by 635
Contributions of polyol pathway to oxidative stress in diabetic cataract
LEE, A. Y. W., & CHUNG, S. S. M. (1999) · The FASEB Journal · doi:10.1096/fasebj.13.1.23 · Cited by 533
Yabe-Nishimura, C. (1998) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01347-4 · Cited by 526
Implications of the United Kingdom Prospective Diabetes Study
American Diabetes Association (2003) · Diabetes Care · doi:10.2337/diacare.26.2007.s28 · Cited by 449
Development of aspirin resistance in persons with previous ischemic stroke.
Helgason, C. M., Bolin, K. M., Hoff, J. A., Winkler, S. R., Mangat, A., Tortorice, K. L., & Brace, L. D. (1994) · Stroke · doi:10.1161/01.str.25.12.2331 · Cited by 408
Grotemeyer, K.-H., Scharafinski, H.-W., & Husstedt, I.-W. (1993) · Thrombosis Research · doi:10.1016/0049-3848(93)90164-j · Cited by 396
Lee, A. Y., Chung, S. K., & Chung, S. S. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.7.2780 · Cited by 310
Epalrestat: An Aldose Reductase Inhibitor for the Treatment of Diabetic Neuropathy
Ramirez, M. A., & Borja, N. L. (2008) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.28.5.646 · Cited by 303
Zimmermann, N., Wenk, A., Kim, U., Kienzle, P., Weber, A.-A., Gams, E., Schrör, K., & Hohlfeld, T. (2003) · Circulation · doi:10.1161/01.cir.0000081770.51929.5a · Cited by 287
A role for mitogen‐activated protein kinases in the etiology of diabetic neuropathy
PURVES, T., MIDDLEMAS, A., AGTHONG, S., JUDE, E. B., BOULTON, A. J. M., FERNYHOUGH, P., & TOMLINSON, D. R. (2001) · The FASEB Journal · doi:10.1096/fj.01-0253hyp · Cited by 274
Oxidative stress as a therapeutic target in diabetes: revisiting the controversy
Wiernsperger, N. (2003) · Diabetes & Metabolism · doi:10.1016/s1262-3636(07)70072-1 · Cited by 257
The role of protein kinase C activation in diabetic nephropathy
Noh, H., & King, G. L. (2007) · Kidney International · doi:10.1038/sj.ki.5002386 · Cited by 212
Cheung, A. K. H., Fung, M. K. L., Lo, A. C. Y., Lam, T. T. L., So, K. F., Chung, S. S. M., & Chung, S. K. (2005) · Diabetes · doi:10.2337/diabetes.54.11.3119 · Cited by 207
Obrosova, I. G., Minchenko, A. G., Vasupuram, R., White, L., Abatan, O. I., Kumagai, A. K., Frank, R. N., & Stevens, M. J. (2003) · Diabetes · doi:10.2337/diabetes.52.3.864 · Cited by 201
Inactivation of cellular enzymes by carbonyls and protein-bound glycation/glycoxidation products
Morgan, P. E., Dean, R. T., & Davies, M. J. (2002) · Archives of Biochemistry and Biophysics · doi:10.1016/s0003-9861(02)00222-9 · Cited by 197
Aldose reductase inhibitors: therapeutic implications for diabetic complications
Oates, P. J., & Mylari, B. L. (1999) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.8.12.2095 · Cited by 197
Le mécanisme de la transformation de glucose en fructose par les vésicules séminales
Hers, H. G. (1956) · Biochimica et Biophysica Acta · doi:10.1016/0006-3002(56)90247-5 · Cited by 186
Implications of the Diabetes Control and Complications Trial
American Diabetes Association (2003) · Diabetes Care · doi:10.2337/diacare.26.2007.s25 · Cited by 182
Macchi, L., Christiaens, L., Brabant, S., Sorel, N., Allal, J., Mauco, G., & Brizard, A. (2002) · Thrombosis Research · doi:10.1016/s0049-3848(02)00210-4 · Cited by 180
Obrosova, I. G., Pacher, P., Szabó, C., Zsengeller, Z., Hirooka, H., Stevens, M. J., & Yorek, M. A. (2005) · Diabetes · doi:10.2337/diabetes.54.1.234 · Cited by 178
Protein Glycation: Creation of Catalytic Sites for Free Radical Generation
Yim, M. B., Yim, H., Lee, C., Kang, S., & Chock, P. B. (2001) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2001.tb05634.x · Cited by 177
Human aldose reductase expression accelerates diabetic atherosclerosis in transgenic mice
Vikramadithyan, R. K. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24819 · Cited by 176
Yagihashi, S. (2001) · Brain · doi:10.1093/brain/124.12.2448 · Cited by 174
Hamada, Y., Araki, N., Koh, N., Nakamura, J., Horiuchi, S., & Hotta, N. (1996) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1996.1695 · Cited by 169 · cited 1×
“Third, the polyol pathway converts glucose to fructose, and fructose can be further metabolized into fructose-3-phosphate and 3-deoxyglucosone, which are more potent non-enzymatic glycation agent than glucose (Hamada et al., 1996a,b).”
Direct Measurement of Polyol Pathway Activity in the Ocular Lens
González, R. G., Barnett, P., Aguayo, J., Cheng, H.-M., & Chylack, L. T. (1984) · Diabetes · doi:10.2337/diab.33.2.196 · Cited by 165
Glomerular Polyol Accumulation in Diabetes and its Prevention by Oral Sorbinil
Beyer-Mears, A., Ku, L., & Cohen, M. P. (1984) · Diabetes · doi:10.2337/diab.33.6.604 · Cited by 157
Cheng, H., & González, R. G. (1986) · Metabolism · doi:10.1016/0026-0495(86)90180-0 · Cited by 153
Ho, E. C. M., Lam, K. S. L., Chen, Y. S., Yip, J. C. W., Arvindakshan, M., Yamagishi, S., Yagihashi, S., Oates, P. J., Ellery, C. A., Chung, S. S. M., et al. (2006) · Diabetes · doi:10.2337/db05-1497 · Cited by 148
Aldose Reductase Inhibition Protects Diabetic and Nondiabetic Rat Hearts from Ischemic Injury
Ramasamy, R., Oates, P. J., & Schaefer, S. (1997) · Diabetes · doi:10.2337/diab.46.2.292 · Cited by 137
Metabolism, hypoxia and the diabetic heart
Heather, L. C., & Clarke, K. (2011) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2011.01.007 · Cited by 132
Aldose Reductase Is an Obligatory Mediator of the Late Phase of Ischemic Preconditioning
Shinmura, K., Bolli, R., Liu, S.-Q., Tang, X., Kodani, E., Xuan, Y., Srivastava, S., & Bhatnagar, A. (2002) · Circulation Research · doi:10.1161/01.res.0000029970.97247.57 · Cited by 129
Central role for aldose reductase pathway in myocardial ischemic injury
Hwang, Y. C., Kaneko, M., Bakr, S. A., Liao, H., Lu, Y., Lewis, E., Yan, S.-D., Ii, S., Itakura, M., Liu, R., et al. (2004) · The FASEB Journal · doi:10.1096/fj.03-1400com · Cited by 129
Sun, W., Oates, P. J., Coutcher, J. B., Gerhardinger, C., & Lorenzi, M. (2006) · Diabetes · doi:10.2337/db06-0138 · Cited by 129
Surface Oxidase and Oxidative Stress Propagation in Aging
Morré, D. M., Lenaz, G., & Morré, D. J. (2000) · Journal of Experimental Biology · doi:10.1242/jeb.203.10.1513 · Cited by 128
Ramana, K. V., Friedrich, B. M., Tammali, R., West, M., Bhatnagar, A., & Sk, S. (2005) · Diabetes · doi:10.2337/diabetes.54.3.818 · Cited by 126
Tang, W. H., Stitham, J., Gleim, S., Febbo, C. D., Porreca, E., Fava, C., Tacconelli, S., Capone, M. L., Evangelista, V., Levantesi, G., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci59291 · Cited by 124
Self-citationPrice, S. A., Agthong, S., Middlemas, A., & Tomlinson, D. R. (2004) · Diabetes · doi:10.2337/diabetes.53.7.1851 · Cited by 122
den Enden, M. K. V., Nyengaard, J. R., Ostrow, E., Burgan, J., & Williamson, J. R. (1995) · PubMed · Cited by 120
Aldose reductase structures: implications for mechanism and inhibition
El-Kabbani, O. A. L., Ruiz, F. M., Darmanin, C., & Chung, R. (2004) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-003-3403-2 · Cited by 118
Anti-platelet action of isoliquiritigenin, an aldose reductase inhibitor in licorice
Tawata, M., Aida, K., NOGUCHI, T., Ozaki, Y., Kume, S., Sasaki, H., Chin, M., & Onaya, T. (1992) · European Journal of Pharmacology · doi:10.1016/0014-2999(92)90076-g · Cited by 110
Glucose utilization by the polyol pathway in human erythrocytes
Morrison, A. D., Clements, R. S., Travis, S. B., et al. (1970) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(70)91066-1 · Cited by 109
Kawamura, N., Ookawara, T., Suzuki, K., Konishi, K., Mino, M., & Taniguchi, N. (1992) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.74.6.1592880 · Cited by 106
Aldose Reductase-Deficient Mice Develop Nephrogenic Diabetes Insipidus
Ho, H. T. B., Chung, S. K., Law, J. W. S., Ko, B. C. B., Tam, S., Brooks, H. L., Knepper, M. A., & Chung, S. S. M. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.16.5840-5846.2000 · Cited by 105
Glycation, oxidation, and lipoxidation in the development of diabetic complications
Kennedy, A. L., & Lyons, T. J. (1997) · Metabolism · doi:10.1016/s0026-0495(97)90311-5 · Cited by 102
Drel, V. R., Pacher, P., Ali, T. K., Shin, J., Julius, U., El‐Remessy, A. B., & Obrosova, I. G. (2008) · International Journal of Molecular Medicine · doi:10.3892/ijmm.21.6.667 · Cited by 99
Drel, V. R., Pacher, P., Stevens, M. J., & Obrosova, I. G. (2006) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2005.12.034 · Cited by 97
Song, Z. (2003) · Molecular and Cellular Neuroscience · doi:10.1016/s1044-7431(03)00096-4 · Cited by 95
Ramana, K. V., Friedrich, B. M., Bhatnagar, A., & Sk, S. (2002) · The FASEB Journal · doi:10.1096/fj.02-0568fje · Cited by 94
Aldose Reductase Inhibition Restores Endothelial Cell Function in Diabetic Rabbit Aorta
Tesfamariam, B., Palacino, J. J., Weisbrod, R. M., & Cohen, R. A. (1993) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-199302000-00004 · Cited by 94
Aldose Reductase Induced by Hyperosmotic Stress Mediates Cardiomyocyte Apoptosis
Galvez, A. S., Ulloa, J. A., Chiong, M., Criollo, A., Eisner, V., Barros, L. F., & Lavandero, S. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211824200 · Cited by 94
Hamada, Y., Nakamura, J., Naruse, K., Komori, T., Kato, K., Kasuya, Y., Nagai, R., Horiuchi, S., & Hotta, N. (2000) · Diabetes Care · doi:10.2337/diacare.23.10.1539 · Cited by 93
Polyol pathway mediates iron-induced oxidative injury in ischemic–reperfused rat heart
Tang, W. H., Wu, S., Wong, T., Chung, S. K., & Chung, S. S. M. (2008) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2008.05.003 · Cited by 90
Self-citationCardiac Abnormalities in Diabetic Patients With Neuropathy
Johnson, B. F., Nesto, R. W., Pfeifer, M. A., Slater, W., Vinik, A. I., Chyun, D. A., Law, G., Wackers, F. J. T., & Young, L. H. (2004) · Diabetes Care · doi:10.2337/diacare.27.2.448 · Cited by 86
Steele, J., Faulds, D. M., & Goa, K. L. (1993) · Drugs & Aging · doi:10.2165/00002512-199303060-00007 · Cited by 84
Effects of hyperglycemia and hyperinsulinemia on the tissue factor pathway of blood coagulation
Boden, G., & Rao, A. (2007) · Current Diabetes Reports · doi:10.1007/s11892-007-0035-1 · Cited by 74
Ishii, H., Tada, H., & Isogai, S. (1998) · Diabetologia · doi:10.1007/s001250050916 · Cited by 72
Aldose and aldehyde reductases in human tissues
Sk, S., Ansari, N. H., Hair, G. A., & Das, B. (1984) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/0304-4165(84)90399-4 · Cited by 67
Von Willebrand factor in diabetic angiopathy.
Kessler, L., Wiesel, M. L., Attali, P., Mossard, J. M., Cazenave, J., & Pinget, M. (1998) · PubMed · Cited by 66
Contribution of Aldose Reductase to Diabetic Hyperproliferation of Vascular Smooth Muscle Cells
Srivastava, S., Ramana, K. V., Tammali, R., Sk, S., & Bhatnagar, A. (2006) · Diabetes · doi:10.2337/diabetes.55.04.06.db05-0932 · Cited by 66
Jagt, D. L. V., Hunsaker, L. A., Robinson, B., et al. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)38533-3 · Cited by 65
Localization of aldose and aldehyde reductase in the kidney
Terubayashi, H., Sato, S., Nishimura, C., Kador, P. F., & Kinoshita, J. H. (1989) · Kidney International · doi:10.1038/ki.1989.270 · Cited by 65
Role of polyol pathway in nonenzymatic glycation
Hamada, Y., Araki, N., Horiuchi, S., & Hotta, N. (1996) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/11.supp5.95 · Cited by 62
Human Aldose Reductase Expression Accelerates Atherosclerosis in Diabetic Apolipoprotein E−/− Mice
Vedantham, S., Noh, H. L., Ananthakrishnan, R., Son, N. H., Hallam, K. M., Hu, Y., Yu, S., Shen, X., Rosario, R., Lu, Y., et al. (2011) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.111.226902 · Cited by 61
Kasajima, H., Yamagishi, S., Sugai, S., Yagihashi, N., & Yagihashi, S. (2001) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s004280100444 · Cited by 59
Clinical Potential of Aldose Reductase Inhibitors in Diabetic Neuropathy
Hamada, Y., & Nakamura, J. (2004) · Treatments in Endocrinology · doi:10.2165/00024677-200403040-00006 · Cited by 50
Reddy, A. B. M., Ramana, K. V., Srivastava, S., Bhatnagar, A., & Sk, S. (2008) · Endocrinology · doi:10.1210/en.2008-0677 · Cited by 50
Role of Nitric Oxide in Regulating Aldose Reductase Activation in the Ischemic Heart
Kaiserová, K., Tang, X., Srivastava, S., & Bhatnagar, A. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m709671200 · Cited by 47
Ananthakrishnan, R., Kaneko, M., Hwang, Y. C., Quadri, N., Gomez, T., Li, Q., Caspersen, C. S., & Ramasamy, R. (2008) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01012.2008 · Cited by 47
IMPLICATIONS OF THE UNITED KINGDOM PROSPECTIVE DIABETES STUDY
Baldeweg, S. E., & Yudkin, J. S. (1999) · Primary Care Clinics in Office Practice · doi:10.1016/s0095-4543(05)70132-9 · Cited by 44
Aldose Reductase Inhibitors Improve Myocardial Reperfusion Injury in Mice by a Dual Mechanism
Iwata, K., Matsuno, K., Nishinaka, T., Persson, C., & Yabe‐Nishimura, C. (2006) · Journal of Pharmacological Sciences · doi:10.1254/jphs.fp0060218 · Cited by 43
Implications of the Diabetes Control and Complications Trial
American Diabetes Association (2002) · Diabetes Care · doi:10.2337/diacare.25.2007.s25 · Cited by 42
Diabetes Can Alter the Signal Transduction Pathways in the Lens of Rats
Zatechka, D. S., Kador, P. F., García-Castiñeiras, S., & Lou, M. F. (2003) · Diabetes · doi:10.2337/diabetes.52.4.1014 · Cited by 40
Jennings, P. E., Nightingale, S., Guen, C. L. L., Lawson, N., Williamson, J. R., Hoffman, P., & Barnett, A. H. (1990) · Diabetic Medicine · doi:10.1111/j.1464-5491.1990.tb01310.x · Cited by 38
The Activity of Aldose Reductase Is Elevated in Diabetic Mouse Heart
Iwata, K., Nishinaka, T., Matsuno, K., Kakehi, T., Katsuyama, M., Ibi, M., & Yabe‐Nishimura, C. (2007) · Journal of Pharmacological Sciences · doi:10.1254/jphs.fp0070136 · Cited by 35
Liu, H., Luo, Y., Zhang, T., Zhang, Y., Qu, W., Li, Y., Chung, S. S. M., Oates, P. J., & Yang, J. (2011) · Diabetologia · doi:10.1007/s00125-011-2045-4 · Cited by 33
Purification and properties of human liver aldehyde reductases
Petrash, J. M., & Srivastava, S. K. (1982) · Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology · doi:10.1016/0167-4838(82)90402-2 · Cited by 33
Ranirestat as a therapeutic aldose reductase inhibitor for diabetic complications
Giannoukakis, N. (2008) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.17.4.575 · Cited by 30
Characterization of aldose reductase and aldehyde reductase from rat testis
Kawasaki, N., Tanimoto, T., & Tanaka, A. (1989) · Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology · doi:10.1016/0167-4838(89)90090-3 · Cited by 29
Corder, C. N., Braughler, J. M., & Culp, P. (1979) · PubMed · Cited by 29
Dong, F., & Ren, J. T. (2007) · Journal of Hypertension · doi:10.1097/hjh.0b013e32828626d1 · Cited by 26
Cellular Receptors for Advanced Glycation Endproducts
Schmidt, A. M., & Stern, D. (2005) · Elsevier eBooks · doi:10.1533/9781845698393.4.262 · Cited by 16
Is tight glycemic control in type 2 diabetes really worthwhile? No.
Clement, M., Bhattacharyya, O., & Conway, J. R. (2009) · PubMed · Cited by 12
Purification and characterization of aldose reductase and aldehyde reductase from human kidney.
Ansari, N. H., Bhatnagar, A., Liu, S., et al. (1991) · PubMed · Cited by 9
Cited by
Pisoschi, A. M., Pop, A., Iordache, F., Stanca, L., Predoi, G., & Serban, A. I. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112891 · Cited by 816
Yuan, T., Yang, T., Chen, H., Fu, D., Hu, Y., Wang, J., Yuan, Q., Yu, H., Xu, W., & Xie, X. (2019) · Redox Biology · doi:10.1016/j.redox.2018.09.025 · Cited by 743
New insights into the mechanisms of diabetic complications: role of lipids and lipid metabolism
Eid, S., Sas, K. M., Abcouwer, S. F., Feldman, E. L., Gardner, T. W., Pennathur, S., & Fort, P. E. (2019) · Diabetologia · doi:10.1007/s00125-019-4959-1 · Cited by 468
Metabolism of stromal and immune cells in health and disease
Ghesquière, B., Wong, B. W., Kuchnio, A., & Carmeliet, P. (2014) · Nature · doi:10.1038/nature13312 · Cited by 451
Pathogenesis of Chronic Hyperglycemia: From Reductive Stress to Oxidative Stress
Yan, L.-J. (2014) · Journal of Diabetes Research · doi:10.1155/2014/137919 · Cited by 397
Metadata
- Authors
- Tang, W. H., Martin, K. A., & Hwa, J.
- Venue
- Frontiers in Pharmacology
- Publisher
- Frontiers Media SA
- Published
- 2012
- Volume
- 3
- Pages
- 87-87
- ISSN
- 1663-9812 (ISSN-L)
- OpenAlex
- W2066746672
- Cited by
- 458
- References
- 92
- FWCI
- 6.85
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.